[1]
Bushra Khan, Laraib Istafa, Bushra Zardad, Mahnoor Musharaf, and Beenish Salam, “RISK OF ENDOMETRIAL HYPERPLASIA AND MALIGNANCY AMONG WOMEN USING TAMOXIFEN: A COMPARATIVE CLINICAL STUDY”., J Popl Ther Clin Pharmacol, vol. 31, no. 11, pp. 2724–2730, Nov. 2024, doi: 10.53555/2hv25555.